Management of gastroesophageal varices in cirrhotic patients: current status and future directions
Toshikuni, Nobuyuki¹; Takuma, Yoshitaka²; Tsutsumi, Mikihiro^1
1Kanazawa Medical University, Department of Hepatology, Ishikawa. Japón; ²Hiroshima City Hospital, Department of Internal Medicine, Hiroshima. Japón
[Annals of hepatology, México, 2016 Vol. 15 Núm. 3 May-Jun, Pág. 314-325]

Nonalcoholic steatohepatitis in morbid obese patients: coffee consumption vs. disease severity
Barros, Raffaelle K¹; Cotrim, Helma P¹; Daltro, Carla¹; Alves, Erivaldo²; Freitas, Luiz A.R. de³; Daltro, Claudia¹; Oliveira, Yanaihara^1
1Universidade Federal da Bahia, Salvador, Bahia. Brasil; ²Núcleo de Tratamento e Cirurgia da Obesidade, Salvador, Bahia. Brasil; ³Universidade Federal da Bahia, Faculdade de Medicina da Bahia, Salvador, Bahia. Brasil
[Annals of hepatology, México, 2016 Vol. 15 Núm. 3 May-Jun, Pág. 350-355]

Predictors and impacts of hospital readmissions following liver transplantation
Yataco, Maria¹; Cowell, Alissa¹; Waseem, David¹; Keaveny, Andrew P¹; Taner, C. Bu¹; Patel, Tushar^1
1Mayo Clinic, Department of Transplant, Jacksonville, Florida. Estados Unidos de América
[Annals of hepatology, México, 2016 Vol. 15 Núm. 3 May-Jun, Pág. 356-362]

Primary hepatic perivascular epithelioid tumor (PEComa)
Schaeffer, David F¹; Poulin, Michael P^1
1Vancouver General Hospital, Division of Anatomic Pathology, Vancouver, Columbia Británica. Canadá
[Annals of hepatology, México, 2016 Vol. 15 Núm. 3 May-Jun, Pág. 436-437]

Pulmonary vascular clearance of harmful endogenous macromolecules in a porcine model of acute liver failure
Nedredal, Geir I¹; Elvevold, Kjetil²; Chedid, Marcio F³; Ytrebo, Lars M⁴; Rose, Christopher F⁵; Sen, Sambit⁶; Smedsrod, Bard²; Jalan, Rajiv⁷; Revhaug, Arthur^1
1University Hospital of Northern Norway, Department of Digestive Surgery, Troms, Tromso. Noruega; ²University of Tromso, Department of Medical Biology, Troms, Tromso. Noruega; ³Hospital de Clinicas de Porto Alegre, Unidade de Cirurgia, Porto Alegre, Rio Grande do Sul. Brasil; ⁴University Hospital of Northern Norway, Department of Anesthesia and Intensive Care, Troms, Tromso. Noruega; ⁵Universite de Montreal, Hepato-Neuro Laboratory, Montreal, Quebec. Canadá; ⁶Luton & Dunstable University Hospital, Department of Gastroenterology, Luton. Reino Unido; ⁷Royal Free Hospital, Institute of Liver and Digestive Health, Londres. Reino Unido
[Annals of hepatology, México, 2016 Vol. 15 Núm. 3 May-Jun, Pág. 427-435]

Rare biliary cystic tumors: a case series of biliary cystadenomas and cystadenocarcinoma
Banerjee, Abhirup¹; Shah, Sudeep R¹; Singh, Abhiyutthan¹; Joshi, Anand²; Desai, Devendra^2
1Hinduja National Hospital, Division of Gastro-Intestinal Surgery, Maharashtra. India; ²Hinduja National Hospital, Department of Gastroenterology, Maharashtra. India
[Annals of hepatology, México, 2016 Vol. 15 Núm. 3 May-Jun, Pág. 448-452]

Small bowel capsule endoscopy and portal hypertensive enteropathy in cirrhotic patients: results from a tertiary referral centre
Dabos, Konstantinos J¹; Yung, Diana E¹; Bartzis, Leonidas¹; Hayes, Peter C¹; Plevris, John N¹; Koulaouzidis, Anastasios^1
1Royal Infirmary of Edinburgh, Centre of Liver and Digestive Disorders, Edimburgo. Reino Unido
[Annals of hepatology, México, 2016 Vol. 15 Núm. 3 May-Jun, Pág. 394-401]

Utility and limitations of APRI and FIB4 to predict staging in a cohort of nonselected outpatients with hepatitis C
Oliveira, Ana Claudia de¹; El-Bacha, Ibrahin²; Vianna, Monica V²; Parise, Edison R^2
1Universidade Federal de Sao Carlos, Departamento de Medicina, Sao Carlos, Sao Paulo. Brasil; ²Universidade Federal de Sao Paulo, Divisao de Gastroenterologia, Sao Paulo. Brasil
[Annals of hepatology, México, 2016 Vol. 15 Núm. 3 May-Jun, Pág. 326-332]

Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver disease
Shoreibah, Mohamed¹; Raff, Evan²; Bloomer, Joseph¹; Kakati, Donny¹; Rasheed, Khalid³; Singal, Ashwani K¹; Kuo, Yong-Fang^4
1University of Alabama at Birmingham, Division of Gastroenterology and Hepatology, Birmingham, Alabama. Estados Unidos de América; ²University of Alabama at Birmingham, Department of Internal Medicine, Birmingham, Alabama. Estados Unidos de América; ³University of Alabama at Birmingham, Montgomery Program, Montgomery, Alabama. Estados Unidos de América; ⁴University of Texas Medical Branch, Department of Biostatistics, Galveston, Texas. Estados Unidos de América
[Annals of hepatology, México, 2016 Vol. 15 Núm. 2 , Pág. 183-189]

Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis
Hilscher, Moira¹; Enders, Felicity B²; Carey, Elizabeth J³; Lindor, Keith D⁴; Tabibian, James H^3
1Mayo Clinic, Department of Internal Medicine, Rochester, Minnesota. Estados Unidos de América; ²Mayo Clinic, Division of Biomedical Statistics & Informatics, Rochester, Minnesota. Estados Unidos de América; ³Mayo Clinic, Division of Gastroenterology & Hepatology, Scottsdale, Arizona. Estados Unidos de América; ⁴Arizona State University, College of Health Solutions, Phoenix, Arizona. Estados Unidos de América
[Annals of hepatology, México, 2016 Vol. 15 Núm. 2 , Pág. 246-253]

Concordance of sustained virologic response at weeks 4, 12 and 24 post-treatment of hepatitis C in the era of new oral direct-acting antivirals: A concise review
Burgess, Sarah V¹; Hussaini, Trana²; Yoshida, Eric M^2
1Dalhousie University, College of Pharmacy, Halifax, Nova Scotia. Canadá; ²University of British Columbia, Faculty of Pharmaceutical Sciences, Vancouver, Columbia Británica. Canadá
[Annals of hepatology, México, 2016 Vol. 15 Núm. 2 , Pág. 154-159]

Cystic angiosarcoma of the liver. A previously undescribed neoplasm
Cano García, Fernando¹; Athie Athie, Amado de Jesús²; García Gómez, Jaime I³; Chablé Montero, Fredy¹; Albores Saavedra, Jorge^1
1Fundación Clínica Médica Sur, Departamento de Patología, Ciudad de México. México; ²Fundación Clínica Médica Sur, Departamento de Cirugía, Ciudad de México. México; ³Fundación Clínica Médica Sur, Departamento de Radiología, Ciudad de México. México
[Annals of hepatology, México, 2016 Vol. 15 Núm. 2 , Pág. 283-286]

Effect of entecavir on CD4+ T-cell subpopulations in patients with chronic hepatitis B
Zhan-Fei, Tian¹; Zhong-Lan, You¹; Yi, Hong¹; Xue-Mei, Kuang¹; Yu-Ming, Wang^1
1Third Military Medical University, Southwest Hospital, Shapingba, Chongqing. China
[Annals of hepatology, México, 2016 Vol. 15 Núm. 2 , Pág. 174-182]

External validation and comparison of six prognostic models in a prospective cohort of HBV-ACLF in China
Shen,Yi¹; Liu, Yan-Mei¹; Wang, Bin²; Zhu, Yong-Gen²; Wang, Yuan-Yuan¹; Qin, Gang²; Wang, Xu-Lin¹; Ji, Ju-Ling³; Shao, Jian-Guo²; Qin, Yan^4
1Nantong University, School of Public Health, Nantong. China; ²Nantong University, Nantong Third People’s Hospital, Nantong. China; ³Nantong University, Medical School, Nantong. China; ⁴Singapore General Hospital, Department of Internal Medicne, Singapur. Singapur
[Annals of hepatology, México, 2016 Vol. 15 Núm. 2 , Pág. 236-245]

Gene expression profiling reveals key genes and pathways related to the development of non-alcoholic fatty liver disease
Wang, Ruifeng¹; Wang, Xiaobing²; Zhuang, Liwei^1
1Harbin Medical University, Fourth Affiliated Hospital, Harbin, Heilongjiang. China; ²Harbin Medical University, First Affiliated Hospital, Harbin, Heilongjiang. China
[Annals of hepatology, México, 2016 Vol. 15 Núm. 2 , Pág. 190-199]

Good outcomes of liver transplantation for hepatitis C at a low volume centre
Lau, Su Yin¹; Woodman, Richard J³; Silva, Mauricio F²; Muller, Kate¹; Libby, John²; Chen, John W²; Padbury, Robert²; Wigg, Alan J^1
1Flinders Medical Centre, Hepatology and Liver Transplant Medicine Unit, Adelaide, Australia Meridional. Australia; ²Flinders Medical Centre, The South Australian Liver Transplant Unit, Adelaide, Australia Meridional. Australia; ³Flinders University of South Australia, School of Medicine, Adelaide, Australia Meridional. Australia
[Annals of hepatology, México, 2016 Vol. 15 Núm. 2 , Pág. 207-214]

Hepatic immunohistochemistry of bile transporters in progressive familial intrahepatic cholestasis
El-Guindi, Mohamed A¹; Sira, Mostafa M¹; Hussein, Mohsen H¹; Ehsan, Nermine A¹; Elsheikh, Nancy M^1
1Menofiya University, National Liver Institute, Shebin El-koom, Menofiya. Egipto
[Annals of hepatology, México, 2016 Vol. 15 Núm. 2 , Pág. 222-229]

IL-1β siRNA adenovirus benefits liver regeneration by improving mesenchymal stem cells survival after acute liver failure
Ma, Hucheng¹; Shi, Xiaolei¹; Yuan, Xianwen¹; Ding, Yitao^1
1Nanjing University, Medical School, Nanjing, Jiangsu. China
[Annals of hepatology, México, 2016 Vol. 15 Núm. 2 , Pág. 260-270]

Insulin treatment of people with diabetes mellitus and chronic liver disease
Gentile, Sandro¹; Strollo, Felice²; Ceriello, Antonio^3
1Seconda Universita degli Studi di Napoli, Dipartimento di Medicina Clinica e Sperimentale, Nápoles, Campania. Italia; ²Universita degli Studi di Milano, Dipartimento di Scienze Farmacologiche e Biomolecolari, Milán, Lombardia. Italia; ³Hospital Clinic de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer, Barcelona. España
[Annals of hepatology, México, 2016 Vol. 15 Núm. 2 , Pág. 287-288]

Monozygotic twins with NASH cirrhosis: cumulative effect of multiple single nucleotide polymorphisms?
Grove, Jane I¹; Austin, Mark²; Tibble, Jeremy²; Aithal, Guruprasad P¹; Verma, Sumita^2
1Nottingham University Hospitals, Nottingham Digestive Diseases Biomedical Research Unit, Nottingham, Nottinghamshire. Reino Unido; ²Brighton and Sussex University Hospital, Department of Gastroenterology and Hepatology, Brighton, East Sussex. Reino Unido
[Annals of hepatology, México, 2016 Vol. 15 Núm. 2 , Pág. 277-282]